Drugs / omega-3 fatty acid ethyl ester
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT01216982 Comparator | Nov 2010 → Feb 2011 | combat disorder, depressive disorder | United States Department of Defense | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | omega-3 fatty acid ethyl ester | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01216982 ↗ |
| Known as | Lovaza | “Lovaza, omega-3 fatty acid ethyl ester” NCT01216982 ↗ |